ArticleJournal of molecular histology2025
Effects of depression on thyroid function, pathology and ultrasonography in rats.
Article in Journal of molecular histology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association Between Clinical Symptoms and Inflammatory Markers in First-Episode Unmedicated Patients with Major Depressive Disorder.Neuropsychiatric disease and treatment · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate the effects of depression on thyroid function, pathology, and ultrasonography in rats, focusing on inflammatory markers and therapeutic interventions. Depression model rats were randomly divided into three groups: model group, fluoxetine group, and Jingqianshu granules group (10 g/kg/day)—a traditional Chinese medicine with antidepressant and anti-inflammatory effects. Depression was induced through chronic restraint stress. Thyroid function was assessed using serum T3, T4, FT3, FT4, and TSH via ELISA. Immunohistochemistry measured IL-1β, IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ in thyroid tissue. HE staining evaluated histological changes, and ultrasound assessed thyroid echogenicity. The model group showed increased expression of IL-1β, IL-2, IL-6, and TNF-α, and decreased IL-10 and IFN-γ (p < 0.05). Fluoxetine significantly reduced IL-6 (p < 0.05), while Jingqianshu granules notably decreased TNF-α and IL-1β levels (p < 0.05). Thyroid epithelial cells in the model group showed damage, atrophy, and reduced colloid content. Treatment groups showed partial improvement and reduced lymphocyte infiltration. Compared to controls, thyroid echo was significantly diminished in the model group (p < 0.01); treatment groups improved. The model group exhibited elevated FT3 and FT4 levels and reduced TSH, indicating thyroid dysfunction. Both treatment groups showed partial normalization of these hormone levels. Both fluoxetine and Jingqianshu granules alleviated depression-induced thyroid pathological and imaging changes, with Jingqianshu demonstrating partial anti-inflammatory effects and potential as a complementary treatment. Further studies are needed to confirm their efficacy and safety relative to fluoxetine. These findings support further study into depression-related thyroid dysfunction.
Indexed as
Identifiers
40897828What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.